The female stress urinary incontinence treatment device market is projected to grow from USD 0.8 billion in 2025 to USD 1.5 billion by 2035, at a CAGR of 6.1%. Mid-Urethral Slings will dominate with a 43.7% market share, while hospitals will lead the end use segment with a 52.4% share.